Your Search Returned 2 tagged news reports
Phase III clinical trial of its lung cancer drug Alimta showed a significant survival benefit in patients with advanced non-small cell lung cancer.
Tags: Eli Lilly and Co., lung cancer, cancer patients, Lilly Cancer Drug Shows, msn money, Alimta, phase iii, market reports, clinical trial, Indianapolis
The drug maker said Alimta was approved as an initial treatment for the most common form of lung cancer in combination with a standard chemotherapy drug, cisplatin. Alimta was previously approved as a secondary treatment for non-small cell lung cancer,...
Tags: cancer, lung cancer, Alimta, chemotherapy drug